Target intelligence / Profile preview

Ribonucleotide reductase M2 (RRM2)

Target
RRM2
Molecular classification
Enzyme
01

Overview

Ribonucleotide reductase M2 (RRM2) is the small regulatory subunit of ribonucleotide reductase, an essential enzyme for DNA synthesis and repair. It catalyzes the conversion of ribonucleotides to deoxyribonucleotides, providing the precursors necessary for DNA replication and cell proliferation. The activity of RRM2 is tightly regulated in a cell cycle-dependent manner, with expression peaking during S-phase. Overexpression correlates with increased tumor growth, poor prognosis, and drug resistance, making it a potential therapeutic target in various cancers.

Other names
RR2RR2MRibonucleotide reductase regulatory subunit M2Ribonucleoside-diphosphate reductase subunit M2
02

Mechanism of action

Inhibition of ribonucleotide reductase activity to reduce the supply of deoxynucleotide triphosphates (dNTPs), thereby blocking DNA replication and cell proliferation.

03

Biological functions

DNA synthesisDNA repairCell proliferation
04

Disease associations

Cancer
05

Safety considerations

Potential for drug resistanceOverexpression associated with poor prognosis
06

Biomarkers

RRM2 overexpression as a prognostic marker

Beyond the preview

Go deeper on Ribonucleotide reductase M2 (RRM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide reductase M2 (RRM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call